{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:31Z","timestamp":1786118911725,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/01.ncc.0000305722.75647.26","type":"journal-article","created":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T03:14:30Z","timestamp":1209006870000},"page":"182-190","source":"Crossref","is-referenced-by-count":16,"title":["Bone Mineral Density and Bone Turnover in Postmenopausal Women Treated for Breast Cancer"],"prefix":"10.1097","volume":"31","author":[{"given":"Nancy L.","family":"Waltman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice J.","family":"Twiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria J.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada M.","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007.","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.","volume":"349","author":"Goss","year":"2003","journal-title":"NEJM"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ctrv.2005.01.008","article-title":"The causes and treatment of bone loss associated with carcinoma of the breast.","volume":"31","author":"Lester","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","article-title":"Osteopenia and osteoporosis in women with breast cancer.","volume":"6","author":"Ramaswamy","year":"2003","journal-title":"Semin Oncol"},{"issue":"2","key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1188\/05.CJON.177-184","article-title":"Interventions to prevent loss of bone mineral density.","volume":"9","author":"Swenson","year":"2004","journal-title":"Clin J Oncol Nurs"},{"issue":"5","key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1745-7599.2001.tb00035.x","article-title":"Bone mineral density in post menopausal breast cancer survivors.","volume":"13","author":"Twiss","year":"2001","journal-title":"J Am Acad Nurse Pract"},{"issue":"4","key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1547-5069.2003.00333.x","article-title":"Testing an intervention for preventing osteoporosis in postmenopausal breast cancer survivors.","volume":"35","author":"Waltman","year":"2003","journal-title":"J Nurs Scholarsh"},{"issue":"3","key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1525-8610(04)70114-0","article-title":"Osteoporosis for the home care physician, part 1: etiology and current diagnostic strategies.","volume":"5","author":"Hajjar","year":"2004","journal-title":"J Am Med Dir Assoc"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ijc.20826","article-title":"Skeletal health in postmenopausal survivors of early breast cancer.","volume":"114","author":"Mackey","year":"2005","journal-title":"Int J Cancer"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0959-8049(01)00317-3","article-title":"Long-term impact of chemotherapy-induced ovarian failure on bone material density (BMD) in premenopausal breast cancer patients: the effect of adjuvant clodronate treatment.","volume":"37","author":"Vehmanen","year":"2001","journal-title":"Eur J Cancer"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial.","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"issue":"9453","key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.","volume":"23","author":"Winer","year":"2005","journal-title":"J Clin Oncol"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1210\/jcem.84.6.5710","article-title":"Bone densitometry: the best way to detect osteoporosis and to monitor therapy.","volume":"84","author":"Miller","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00330-006-0511-z","article-title":"An update on the assessment of osteoporosis using radiologic techniques.","volume":"17","author":"Damilakis","year":"2007","journal-title":"Eur Radiol"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1359\/jbmr.1999.14.9.1583","article-title":"The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial.","volume":"14","author":"Marcus","year":"1999","journal-title":"J Bone Miner Res"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s001980200068","article-title":"Biochemical indices of bone turnover and the assessment of fracture probability.","volume":"13","author":"Johnell","year":"2002","journal-title":"Osteoporos Int"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.288.15.1889","article-title":"Clinical use of bone densitometry: scientific review.","volume":"288","author":"Cummings","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1359\/JBMR.0301243","article-title":"Relationships between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk.","volume":"19","author":"Sarkar","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.","volume":"19","author":"Shapiro","year":"2001","journal-title":"J Clin Oncol"},{"issue":"8","key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.1999.17.8.2365","article-title":"Risk of menopause during the first year after breast cancer diagnosis.","volume":"17","author":"Goodwin","year":"1999","journal-title":"J Clin Oncol"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","article-title":"Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.","volume":"15","author":"Saarto","year":"1997","journal-title":"J Clin Oncol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.","volume":"14","author":"Bines","year":"1996","journal-title":"J Clin Oncol"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","article-title":"Osteoporosis due to cancer treatment: pathogenesis and management.","volume":"18","author":"Pfeilschifter","year":"2000","journal-title":"J Clin Oncol"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0959-8049(97)10135-6","article-title":"Bone loss induced by cancer treatment and its management.","volume":"34","author":"Delmas","year":"1998","journal-title":"Eur J Cancer"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"issue":"suppl 2","key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1525-1438.2006.00685.x","article-title":"Bone safety of aromatase inhibitors versus tamoxifen.","volume":"16","author":"Lonning","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"18","key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"60","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R37-4-20210203","first-page":"675","article-title":"Bone effects of tamoxifen tied to menstrual status.","volume":"24","author":"Douglas","year":"2006","journal-title":"J Clin Oncol"},{"issue":"13","key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.","volume":"14","author":"Powles","year":"1996","journal-title":"J Clin Oncol"},{"issue":"suppl 14","key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0093-7754(03)00302-6","article-title":"Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.","volume":"30","author":"Miller","year":"2003","journal-title":"Semin Oncol Nurs"},{"issue":"suppl 18","key":"R41-4-20210203","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/jco.2006.24.18_suppl.511","article-title":"ATAC Trialists' Group. Effect of anastrozole on bone mineral density: 5-year results of 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial. ASCO annual meeting proceedings, part 1.","volume":"24","author":"Coleman","year":"2006","journal-title":"J Clin Oncol"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analysis.","volume":"98","author":"Baum","year":"2003","journal-title":"Cancer"},{"key":"R43-4-20210203","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1586\/14737140.6.6.849","article-title":"Extended adjuvant therapy with letrazole: reducing the risk of recurrence.","volume":"6","author":"Dixon","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"R44-4-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00002820-200601000-00004","article-title":"Challenges of recruitment of breast cancer survivors to a randomized clinical trial for osteoporosis prevention.","volume":"29","author":"Ott","year":"2006","journal-title":"Cancer Nurs"},{"issue":"suppl","key":"R45-4-20210203","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1385\/JCD:5:3S:S11","article-title":"International Society for Clinical Densitometry Position Development Panel and Scientific Advisory Committee. Which central dual x-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis?","volume":"5","author":"Hamdy","year":"2002","journal-title":"J Clin Densitom"},{"key":"R46-4-20210203","first-page":"S344","article-title":"Assessment and improvement of longitudinal precision and in vivo dual x-ray absorptiometry spine and femur scans.","volume":"8","author":"Brastow","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R47-4-20210203","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results.","volume":"9","author":"Genant","year":"1994","journal-title":"J Bone Miner Res"},{"key":"R48-4-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"R51-4-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1037\/1082-989X.7.2.147","article-title":"Missing data: our view of the state of the art.","volume":"7","author":"Schafer","year":"2002","journal-title":"Psychol Methods"},{"issue":"14","key":"R53-4-20210203","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/0959-8049(93)90454-N","article-title":"Does long-term administration of tamoxifen affect bone mineral density?","volume":"29A","author":"Neal","year":"1993","journal-title":"Eur J Cancer"},{"key":"R54-4-20210203","doi-asserted-by":"crossref","first-page":"M101","DOI":"10.1093\/geronj\/45.3.M101","article-title":"Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study.","volume":"45","author":"Magaziner","year":"1990","journal-title":"J Gerontol"}],"container-title":["Cancer Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.NCC.0000305722.75647.26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:00Z","timestamp":1786036020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002820-200805000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ncc.0000305722.75647.26","relation":{},"ISSN":["0162-220X"],"issn-type":[{"value":"0162-220X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}